EUVIMEDEUVIMED entdecken
Open Access

Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment

Burcu Gunaydin, Gurkan Yigitturk, Hulya Elbe

Romanian Journal of Morphology and Embryology · 2023

DOI: 10.47162/rjme.64.3.07 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Morphology and Embryology, 2023. Verfasst von Burcu Gunaydin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla, Türkiye; hulya.elbe@mu.edu.tr. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ovarian Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Today, many anticancer drugs are used clinically for ovarian cancer, one of the leading causes of cancer-related deaths in women. Phenformin is an antidiabetic drug of the biguanide class. It improves the antiproliferative activity in cancer cells. Hypoxia is an important component associated with ovarian cancer and its tumor microenvironment. The aim of this study was to investigate the anticancer effects of Phenformin in SKOV-3 human ovarian cancer cells under hypoxic conditions. SKOV-3 human ovarian cancer cells treated with different doses of Phenformin (0.5 mM, 1 mM, 2 mM, 5 mM) for 24 hours were subjected to WST-1 cell viability assay and Annexin V apoptosis assay. A dose-dependent decrease in cell viability with Phenformin treatment was observed. In addition, Phenformin activated percentage of apoptotic SKOV-3 cancer cells in a dose-dependent manner. In this study, Cobalt(II) chloride (CoCl2) treatment leads to increased hypoxia-inducible factor-1alpha (HIF-1α) expression and Phenformin can recover hypoxic condition. HIF-1α protein expression was significantly correlated with cell viability assay and apoptosis assay. We also found that Phenformin inhibits expression of phosphoinositide-dependent kinase 1 (PDK1) in SKOV-3 ovarian cancer cells. The ability to migrate to cancer cells was significantly reduced in a dose-dependent manner with Phenformin. This data demonstrates that Phenformin treatment can induce apoptosis and inhibit proliferation in ovarian cancer cells under hypoxic conditions. The findings reveal that HIF-1α is a new target for the treatment of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOvarian NeoplasmsFemaleHumansCell HypoxiaCell Line, TumorCell ProliferationHypoxiaHypoxia-Inducible Factor 1, alpha SubunitPhenforminTumor Microenvironment

Substanzen

Antineoplastic AgentsHypoxia-Inducible Factor 1, alpha SubunitPhenformin

Autor:innen und Institutionen

  • Department of Histology and Embryology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla, Türkiye; hulya.elbe@mu.edu.tr.

Zitieren

APA

Gunaydin, B., Yigitturk, G., & Elbe, H. (2023). Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment. Romanian Journal of Morphology and Embryology. https://doi.org/10.47162/rjme.64.3.07

Vancouver

Gunaydin B, Yigitturk G, Elbe H. Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment. Romanian Journal of Morphology and Embryology. 2023. doi:10.47162/rjme.64.3.07

BibTeX
@article{Gunaydin2023,
  author = {Gunaydin, Burcu and Yigitturk, Gurkan and Elbe, Hulya},
  title = {Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment},
  journal = {Romanian Journal of Morphology and Embryology},
  year = {2023},
  doi = {10.47162/rjme.64.3.07}
}
Kostenlos starten →